about
Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort studyEpidemiology of meningitis in an HIV-infected Ugandan cohortEvolving Failures in the Delivery of Human Immunodeficiency Virus Care: Lessons From a Ugandan Meningitis Cohort 2006-2016.Unmasking cryptococcal meningitis immune reconstitution inflammatory syndrome in pregnancy induced by HIV antiretroviral therapy with postpartum paradoxical exacerbation.Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohortsTiming of antiretroviral therapy after diagnosis of cryptococcal meningitis.Central nervous system cryptococcoma in a Ugandan patient with Human Immunodeficiency VirusStandardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settings.Accuracy of noninvasive intraocular pressure or optic nerve sheath diameter measurements for predicting elevated intracranial pressure in cryptococcal meningitis.Detection of High Cerebrospinal Fluid Levels of (1→3)-β-d-Glucan in Cryptococcal MeningitisThe effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis.Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study.Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial.Cryptococcal Meningitis: Diagnosis and Management Update.Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda.Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal Meningitis.Brief Report: Effects of Tenofovir and Amphotericin B Deoxycholate Coadministration on Kidney Function in Patients Treated for Cryptococcal MeningitisHuman Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding.Diagnostic performance of a multiplex PCR assay for meningitis in an HIV-infected population in Uganda.Improved diagnostic sensitivity for tuberculous meningitis with Xpert(®) MTB/RIF of centrifuged CSF.Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitisOutcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy.Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis.Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal Meningitis.Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitisSertraline for HIV-associated cryptococcal meningitis - Authors' reply.1,3-β-D-glucan in cryptococcal meningitis.Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis.Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detection.Cryptococcal Disease in the Era of "Test and Treat": Is There Cause for Concern?Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluid.Symptomatic cryptococcal antigenemia presenting as early cryptococcal meningitis with negative CSF analysisCryptococcal Meningitis and Tuberculous Meningitis Co-infection in HIV-Infected Ugandan AdultsDelta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitisCan improved diagnostics reduce mortality from Tuberculous meningitis? Findings from a 6.5-year cohort in UgandaDetrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART InitiationHIV-associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 countsOphthalmic signs in Ugandan adults with HIV-associated cryptococcal meningitis: A nested analysis of the ASTRO-CM cohort
P50
Q21144623-26491924-7CA3-4D6D-8909-1CCF4F828E5FQ24273288-9EEC70A3-39EC-48D1-9293-E9D96C7AD8DCQ33747751-247D48B6-390B-4299-A06C-8CB8A64F8860Q33765829-1AEE7427-4B5D-4D4A-9AE1-7A0D804D5675Q33792332-8D645A91-0470-40B8-AD06-452A3B22E62FQ34024416-DFBAD75C-30D7-4422-B027-793BB0DDF661Q34436150-D3D42D6C-568D-40FA-8360-2E5D4B35C10CQ34801921-86EDA151-1F79-44FB-A4D3-780DE42FC0EEQ35072051-EBE869CC-903F-4A03-A529-52C1ED920CA2Q35072106-5B10213B-7133-4774-A2DF-8B6E92B4EB3FQ35635476-5C05609F-562C-4A79-A2B7-E0C7DD40E7DEQ35855950-DF4A9932-E521-4270-BCDC-D26F5991B00AQ35923885-775FB163-2D81-4937-9676-3D73A47B6811Q35951094-FEF4F790-9486-4790-BCFA-D9E2B4BEEA33Q36290696-79D8EFD1-7D82-41A9-8C7A-44BD365678C4Q36407524-A7D1D090-1BCF-4CB5-9B9A-C50E5A6C719FQ36463811-1600CB02-E3A9-4F23-BEF2-C250640C3D63Q36488971-3B984719-97AA-43EC-A9A1-1DF4ACD9FE19Q36609745-0BB2D066-6D07-42FE-81BE-423F46455340Q36622358-215B31BF-34E2-4DE1-8FF7-74B38F22C0A4Q36807382-7DF5579A-24F4-4F27-BD15-BAC47161E835Q36996124-70BB07C3-F127-49EA-B080-4F0EBBFDFE06Q37052988-0B82D673-FAA1-4078-B40C-25A509E6E74FQ38849132-9F570982-81C8-435F-8C71-2923D9BC6F3DQ38850833-F77633A2-63A6-4FD0-9A79-85FDC1CE0285Q38851467-341F6C8C-7289-43A4-ADEE-F1577E749E74Q38854793-EE056549-2D28-4B10-88C5-DA4FEC715461Q42372326-3B782AF6-9E51-45D1-A360-CBDEA2D352C1Q46816304-767E7572-2CF5-436A-B14D-925788FA0227Q47139593-49C7B29C-E4BA-42B3-A4FD-F2F1924EEC98Q48303014-02AA3E76-194C-4870-8EF0-AE7CD50B788DQ49672562-D51DEC1F-8938-4A77-B127-F1E3180ABA25Q50053465-C94D66AD-13C7-4404-B20A-67BC5FB09AE3Q56909109-4D10A6CE-A03E-4DAB-A869-ED5C1B49E0C9Q56910027-D57C5B08-71DC-4051-8DD4-D89F8BB74458Q56911556-22880445-2052-4151-89F1-CC6F167E4526Q56912105-5724C172-FE7E-4207-A583-18C4DC87B8DDQ56912128-2CAB6E8B-C4DE-4432-8CBB-6BA6B8F833E4Q57458281-061D49D4-3277-4068-88B4-EBCDC7B3E5B9Q57815720-ED2C89BD-8B3A-40EE-BA27-21DCE4FB3042
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joshua Rhein
@ast
Joshua Rhein
@en
Joshua Rhein
@es
Joshua Rhein
@nl
Joshua Rhein
@sl
type
label
Joshua Rhein
@ast
Joshua Rhein
@en
Joshua Rhein
@es
Joshua Rhein
@nl
Joshua Rhein
@sl
prefLabel
Joshua Rhein
@ast
Joshua Rhein
@en
Joshua Rhein
@es
Joshua Rhein
@nl
Joshua Rhein
@sl
P106
P1153
36679220100
P21
P31
P496
0000-0002-0480-9646